---
title: "SL PHARM: Net profit loss of 74.0657 million yuan in 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236798045.md"
description: "SL PHARM announced that the operating revenue for 2024 is 660 million yuan, a year-on-year decrease of 35.15%. The net profit attributable to shareholders of the listed company is -74.0657 million yuan, a year-on-year decrease of 117.77%. The basic earnings per share is -0.07 yuan/share. The company plans to distribute a cash dividend of 0.2 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital"
datetime: "2025-04-21T12:46:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236798045.md)
  - [en](https://longbridge.com/en/news/236798045.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236798045.md)
generator: "portal-rs"
---

# SL PHARM: Net profit loss of 74.0657 million yuan in 2024

SL PHARM announced that the operating revenue for 2024 is 660 million yuan, a year-on-year decrease of 35.15%. The net profit attributable to shareholders of the listed company is -74.0657 million yuan, a year-on-year decrease of 117.77%. The basic earnings per share is -0.07 yuan/share. The company plans to distribute a cash dividend of 0.2 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital

### Related Stocks

- [002038.CN](https://longbridge.com/en/quote/002038.CN.md)

## Related News & Research

- [Manufacturers are getting frustrated: 'The economy is annoying'](https://longbridge.com/en/news/297685808.md)
- [Manufacturers are getting frustrated: 'The economy is annoying'](https://longbridge.com/en/news/297686341.md)
- [U.S. job openings rise to 7.271 million in July](https://longbridge.com/en/news/297664395.md)
- [13:41 ETRice University builds momentum with record demand, historic growth](https://longbridge.com/en/news/297683754.md)
- [Patriot Resources wins conditional CSE approval for listing move from TSXV NEX board](https://longbridge.com/en/news/297785904.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**